◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksG › GLAS

Glass House Brands Inc. (GLAS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-09-19

Glass House Brands Inc. (GLAS) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Long Beach, United States with about 357 employees. Its market capitalization is roughly $800 million. In the fiscal year ended 2025-12-31, GLAS reported $182M in revenue and ($30M) in net income.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

Interactive charts & full statements → Open the GLAS valuation workbench →

GLAS Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Total Revenue$165M$182M$201M$161M$85M
Gross Profit$51M$77M$97M$81M$21M
Gross Margin %30.8%42.3%48.5%50.3%24.4%
Operating Income (EBIT)($41M)($15M)$12M$3M($51M)
Operating Margin %-25.1%-8.0%6.0%2.0%-59.6%
Net Income($52M)($30M)$1M($98M)($33M)
Net Margin %-31.7%-16.3%0.3%-61.1%-38.8%
EBITDA
Earnings Per Share (EPS)$-0.63$-0.36$0.01$-1.39$-0.48
Shares Outstanding (M)89M82M77M71M68M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GLAS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$47M$41M$39M$38M$48M$45M
Gross Profit$16M$10M$13M$12M$26M$20M
Gross Margin %33.5%24.7%34.0%30.6%54.8%44.8%
Operating Income (EBIT)($3M)($14M)($13M)($11M)$10M($1M)
Operating Margin %-6.4%-35.4%-32.6%-29.6%21.6%-2.7%
Net Income($7M)($17M)($16M)($12M)$9M($10M)
Net Margin %-14.5%-42.3%-41.1%-32.0%18.2%-22.3%
EBITDA
Earnings Per Share (EPS)$-0.08$-0.20$-0.20$-0.15$0.11$-0.13
Shares Outstanding (M)89M85M82M80M79M77M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GLAS Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Cash from Operations (CFO)($20M)$11M$28M$23M($41M)
Capital Expenditures (CapEx)$17M$27M$10M$12M$28M
Free Cash Flow (FCF)($37M)($16M)$18M$11M($69M)
FCF Margin %-22.5%-8.6%9.0%6.8%-80.8%
Dividends Paid$10M$8M$8M$6M$4M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GLAS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Cash from Operations (CFO)$0M($12M)($4M)($5M)$18M$2M
Capital Expenditures (CapEx)$2M$4M$2M$9M$9M$7M
Free Cash Flow (FCF)($2M)($15M)($6M)($14M)$8M($4M)
FCF Margin %-4.1%-37.8%-15.7%-35.6%17.4%-9.4%
Dividends Paid$3M$3M$2M$2M$2M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GLAS Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-31
Total Assets$313M$319M$311M$304M$351M
Cash & Cash Equivalents$19M$20M$34M$30M$11M
Total Liabilities$241M$236M$161M$174M$181M
Total Debt (Short + Long-Term)$55M$69M$51M$57M$63M
Total Shareholders' Equity$73M$74M$116M$90M$169M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GLAS viewer.

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

← GLANDAll “G” companiesGLASSWALL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.